Skip to main content
Clinical Trials/NCT01220986
NCT01220986UnknownNot Applicable

An Observational Study of Liver Regeneration After Right Hepatectomy: Understanding the Molecular Primers of Liver Regeneration

Nottingham University Hospitals NHS Trust1 site in 1 country20 target enrollmentStarted: August 2010Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
20
Locations
1

Study Overview

Brief Summary

The aim of this study is to characterize Kupffer cell activity and activation of the innate immune response in the early phase of liver regeneration after right hepatectomy. The investigators hypothesise that liver regeneration after right hepatectomy in humans is associated with Kupffer cell activation and initiation of the innate immune response and that impaired liver regeneration, liver failure and sepsis following liver resection are associated with Kupffer cell dysfunction and an impaired innate immune response. The objectives for this study are to characterise Kupffer cell activity and the innate immune response in human liver before and after right hepatectomy.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients requiring right hepatectomy for colorectal liver metastases

Exclusion Criteria

  • Age >75, neoadjuvant chemotherapy, recurrent disease

Investigators

Study Sites (1)

Loading locations...

Similar Trials

Liver Regeneration After Liver Resection | Clinical Trial